Takeda Pharmaceutical
TAK
#401
Rank
A$81.73 B
Marketcap
A$25.87
Share price
1.01%
Change (1 day)
10.86%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): A$4.93 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are A$29.86 Billion. , an increase over its 2024 earnings that were of A$3.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 A$4.76 B49.03%
2024 A$3.20 B-2.41%
2023 A$3.27 B-28.14%
2022 A$4.56 B-40.9%
2021 A$7.72 B78.24%
2020 A$4.33 B246.1%
2019 A$1.25 B-48.79%
2018 A$2.44 B-23.64%
2017 A$3.20 B21.7%
2016 A$2.62 B-253.01%
2015 -A$1.72 Billion-159.65%
2014 A$2.88 B13%
2013 A$2.54 B2.46%
2012 A$2.48 B-57.05%
2011 A$5.79 B-10.49%
2010 A$6.47 B-3.99%
2009 A$6.74 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.11 B 908.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$23.45 B 391.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.61 B 206.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.87 B 169.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.04 B 131.51%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$32.15 B 574.24%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.19 B 197.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-A$1.14 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$1.25 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India